The largest and most comprehensive event of its kind where science meets business, investors meet new projects and start-ups, buyers meet sellers Singapore, 31 March 2008 - More than 1,000 leading global biomedical industry players will convene in Singapore from 14-17 April 2008 to attend the BioMedical Asia 2008 Conference & Exhibition. Biomedical Asia 2008 will be a unique platform to learn from successful case studies in Asia and forge strategic partnerships with industry movers and shakers, with six main conferences, seven focused industry summits and masterclasses, and the participation of 200 international speakers. Held in Singapore, a hub for the biomedical industry, the event will bring together multi-national pharmaceutical companies, biotechs, research institutions, regulators, investors, physicians and other key stakeholders. Asia's leading biopharmaceutical companies that will be represented in the conference include Chugai Pharma, Eisai Pharma, Kirin Pharma, LG Life Sciences, MerLion Pharma, Reliance Life Sciences, Shanghai Cell Engineering & Antibody Centre, Serum Institute of India. Participants will discuss latest discoveries, partnership opportunities, viable business ventures and best industry practices with leading industry representatives from the US and Europe as well as global biotech venture capitalists Novartis Venture Fund, Coastview Capital, MPM Capital and many others. Singapore's Minister for Trade & Industry, Mr Lim Hng Kiang, will officially open Biomedical Asia 2008. Gordon Binder (Managing Director, Coastview Capital and Founder/Former CEO, Amgen Inc), Philippe Kourilsky (Chair of Molecular Immunology, College de France and Former Director General, Pasteur Institute, France), and Ansbert Gadicke (Founder and General Partner, MPM Group) will speak at the opening plenary that is moderated by Lorraine Hahn, former anchor with CNN and CNBC. Commenting on the significance of BioMedical Asia 2008, Mr Richard Ireland, Chief Executive - Asia Pacific, Terrapinn said, "Compared with North America and Europe, the biomedical sector in Asia Pacific is set to grow swiftly given its vast potential. As the industry is still young, it will be good for us to work more closely together and achieve strategic and synergistic alignment. Our ultimate goal for BioMedical Asia 2008 is to promote the learning and use of cost-effective drug development and manufacturing solutions to improve healthcare services and its accessibility. BioMedical Asia 2008 will also provide participants the opportunity to network with their peers from other related industries." Ms Aw Kah Peng, Assistant Managing Director, Singapore Economic Development Board added, "Situated at geographical crossroads between the East and the West, Singapore is a cosmopolitan city in the heart of Asia where global scientific and business leaders congregate. We are pleased to support Biomedical Asia 2008 and are confident that the conference and showcase will promote fruitful exchanges across both cultural and scientific boundaries." Speaking at the conference will be top minds across 140 pharmaceutical companies, biotech companies, life sciences investors, industry specialists, non-profit organisations, research institutions and universities, technology and solution providers, contract service providers, government and regulatory bodies, including those of Australia, China, Germany, France, Hong Kong, India, Japan, Malaysia, United Kingdom and the United States. Delegates will have the opportunity to explore new products and new ways of thinking in the healthcare space. For more information about BioMedical Asia 2008, visit: <http://www.biomedicalasia.com> Note to Editors: Dear Editor, BioMedical Asia 2008 will be organizing a press conference on Tuesday, 15 April 2008, 10.30am to 11am. Engage top leaders from multi-national pharmaceutical companies, biotechs, research institutions, regulators, investors, physicians and other key stakeholders come together, including: Latest discoveries; Partnership opportunities; Viable business ventures & Best industry practices Please let us know if you or/and your photographer/ cameraman would be able to attend this press conference by 11 April 2008. To confirm your attendance and for media enquiries, please contact: Mathew Thomas Senior Account Manager Ogilvy Health, Singapore Tel: 6213 7959 Mobile: 9068 7108 Email: mathew.thomas@ogilvy.com Yeo Wee Kiat Senior Account Executive Ogilvy Health, Singapore Tel: 6213 7722 Mobile: 9126 3095 Email: weekiat.yeo@ogilvy.com For queries on registration matters, please contact: Lynn Chew Marketing Manager Terrapinn Phone: +65 6322 2729 Fax: +65 6226 3264 Email: lynn.chew@terrapinn.com About BioMedical Asia 2008 BioMedical Asia 2008 is the largest and most comprehensive biomedical event in Asia Pacific where top minds from every continent will convene. Featuring 6 conferences, 2 summits and 5 workshops, BioMedical Asia 2008 is the only biomedical event in Asia offering you an unparalleled opportunity to meet and network with over 1,000 biomedical scientists and executives from different parts of the biomedical industry value chain. Supported by regional bodies such as A*STAR, Bio*One Capital, Singapore Economic Development Board and the Singapore Tourism Board, this is Asia's most prestigious biomedical event of the year. For more information or to register, please call on +65 322 2710 / 770 or visit the website at www.biomedicalasia.com